BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2887665)

  • 1. Differential effect of mu, delta, and kappa opioid agonists on adenylate cyclase activity.
    De Montis GM; Devoto P; Preti A; Tagliamonte A
    J Neurosci Res; 1987; 17(4):435-9. PubMed ID: 2887665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of opioid receptor agonists on nociception and cAMP level in the spinal cord of monoarthritic rats.
    Przewłocka B; Dziedzicka M; Lasoń W; Przewłocki R
    Life Sci; 1992; 50(1):45-54. PubMed ID: 1345879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
    Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of opioid receptors modulating the function of capsaicin-sensitive neurons in guinea-pig atria.
    Mantelli L; Amerini S; Rubino A; Ledda F
    Eur J Pharmacol; 1990 May; 180(2-3):325-30. PubMed ID: 1973118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
    Izenwasser S; Búzás B; Cox BM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR; Makhlouf GM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
    Dunwiddie TV; Johnson KJ; Proctor WR
    Br J Pharmacol; 1987 Jul; 91(3):523-30. PubMed ID: 3038241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
    de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
    J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
    De Vries TJ; Hogenboom F; Mulder AH; Schoffelmeer AN
    Brain Res Dev Brain Res; 1990 Jun; 54(1):63-9. PubMed ID: 2163782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ; Mulder AH; Schoffelmeer AN
    J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specific opioid kappa-agonist U-50,488H inhibits low Km GTPase.
    Ueda H; Misawa H; Fukushima N; Takagi H
    Eur J Pharmacol; 1987 Jun; 138(1):129-32. PubMed ID: 3040426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential antagonism of U69,593- and bremazocine-induced antinociception by (-)-UPHIT: evidence of kappa opioid receptor multiplicity in mice.
    Horan P; de Costa BR; Rice KC; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1154-61. PubMed ID: 1646325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of dynorphin A on in vitro guinea pig hippocampal CA3 pyramidal cells with various degrees of paired-pulse facilitation.
    Iwama T; Ishihara K; Satoh M; Takagi H
    Neurosci Lett; 1986 Jan; 63(2):190-4. PubMed ID: 2869458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs.
    Werling LL; Frattali A; Portoghese PS; Takemori AE; Cox BM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):282-6. PubMed ID: 2839666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
    Olianas MC; Onali P
    Mol Pharmacol; 1992 Jul; 42(1):109-15. PubMed ID: 1321951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central effects of mu, delta, and kappa receptor agonists in hemorrhagic shock.
    Feuerstein G; Powell E; Faden AI
    Peptides; 1985; 6 Suppl 1():11-3. PubMed ID: 2995939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiographic localization in rat brain of kappa opiate binding sites labelled by [3H]bremazocine.
    Morris BJ; Herz A
    Neuroscience; 1986 Nov; 19(3):839-46. PubMed ID: 3025770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delta and kappa opiate receptors in primary astroglial cultures. Part II: Receptor sets in cultures from various brain regions and interactions with beta-receptor activated cyclic AMP.
    Eriksson PS; Hansson E; Rönnbäck L
    Neurochem Res; 1992 Jun; 17(6):545-51. PubMed ID: 1318509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.